Literature DB >> 18949947

Interferon-alpha in the management of patients with Behçet's disease.

David S F Yang1, Simon R J Taylor, Sue L Lightman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18949947     DOI： 10.12968/hmed.2008.69.10.31317

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN： 1750-8460            Impact factor:   0.825


× No keyword cloud information.
  8 in total

Review 1.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

Review 2.  Current and future treatments for Behçet's uveitis: road to remission.

Authors:  Marina Mesquida; Blanca Molins; Victor Llorenç; María Victoria Hernández; Gerard Espinosa; Andrew D Dick; Alfredo Adán
Journal:  Int Ophthalmol       Date:  2013-06-01       Impact factor: 2.031

3.  AAV2-mediated combined subretinal delivery of IFN-α and IL-4 reduces the severity of experimental autoimmune uveoretinitis.

Authors:  Lichun Tian; Bo Lei; Ju Shao; Lin Wei; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

4.  AAV2-mediated subretinal gene transfer of hIFN-α attenuates experimental autoimmune uveoretinitis in mice.

Authors:  Lichun Tian; Peizeng Yang; Bo Lei; Ju Shao; Chaokui Wang; Qin Xiang; Lin Wei; Zhougui Peng; Aize Kijlstra
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

5.  Evaluation of serum interferons in patients with age-related macular degeneration.

Authors:  Mehrdad Afarid; Ali Azimi; Mahyar Malekzadeh
Journal:  J Res Med Sci       Date:  2019-03-25       Impact factor: 1.852

6.  The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome.

Authors:  Guzin Ozcifci; Tahacan Aydin; Zeynep Atli; Ilker Inanc Balkan; Fehmi Tabak; Mert Oztas; Yesim Ozguler; Serdal Ugurlu; Gulen Hatemi; Melike Melikoglu; Izzet Fresko; Vedat Hamuryudan; Emire Seyahi
Journal:  Rheumatol Int       Date:  2021-11-25       Impact factor: 3.580

7.  Interferons and their potential in the treatment of ocular inflammation.

Authors:  Friederike Mackensen; Regina Max; Matthias D Becker
Journal:  Clin Ophthalmol       Date:  2009-10-19

Review 8.  Birdshot uveitis: current and emerging treatment options.

Authors:  Victor Menezo; Simon Rj Taylor
Journal:  Clin Ophthalmol       Date:  2013-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.